Multicellular living organisms and unmodified parts thereof and – Nonhuman animal
Patent
1994-07-12
1997-11-04
Stanton, Brian R.
Multicellular living organisms and unmodified parts thereof and
Nonhuman animal
424 92, 4351723, 43524021, 800DIG1, 800DIG2, A61K 3100, C12N 506, C12N 1506, C12N 1585
Patent
active
056842228
ABSTRACT:
The multiple biological activities of tumor necrosis factor (TNF) are mediated by two distinct cell surface receptors of 55 and 75 kDa. Mutant mice of the invention lacking tumor necrosis factor receptor (TNFR) p55 still express functional TNFRp75 molecules at the cell surface. Normal weight and size of the mutant mice are not altered. Thymocyte development and lymphocyte populations are normal, and clonal deletion of potentially self-reactive T cells is not impaired. Activation of the nuclear transcription factor .kappa.B (NF-.kappa.B), however, is completely abrogated after stimulation with TNF. Moreover, TNFRp55 mutant mice are protected from septic shock induced by bacterial endotoxin or superantigen, but Listeria clearance is severely impaired and mutant mice easily succumb to Listeria infection. Thus, the two TNF receptors are not redundant, are independently controlled, and play different roles in normal and pathological physiology.
REFERENCES:
Ashkenazi et al., "Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin", Proc. Natl. Acad. Sci. USA 88:10535-10539 (1991).
Baeuerle, "The inducible transcription activator NF-.kappa.B: regulation by distinct protein subunits", Biochimica et Biophysica Acta 1072:63-80 (1991).
Beutler et al., "The Biology of Cachectin/TNF--A Primary Mediator of the Host Response", Ann. Rev. Immunol. 7:625-655 (1989).
Buetler et al., "Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of Endotoxin", Science 229:869-871 (1985).
Bradley et al., "Embryo-Derived Stem Cells: A Tool for Elucidating the Developmental Genetics of the Mouse", Current Topic in Developmental Biology 20:357-371 (1986).
Camerini et al., "The T Cell Activation Antigen CD27 is a Member of the Nerve Growth Factor/Tumor Necrosis Factor Receptor Gene Family", The Journal of Immunology 147(9):3165-3169 (1991).
Capecchi, "Altering the Genome by Homologous Recombination", Science 244:1288-1292 (1989).
de Kossodo et al., "Tumor Necrosis Factor .alpha. is Involved in Mouse Growth and Lymphoid Tissue Development", J. Exp. Med. 176:1259-1264 (1992).
Giroir et al., "Constitutive synthesis of tumor necrosis factor in the thymus", Proc. Natl. Acad. USA 89:4864-4868 (1992).
Giroir et al., "The Tissue Distribution of Tumor Necrosis Factor Biosynthesis During Endotoxemia", J. Clin. Invest 90:693-698 (1992).
Goodwin et al., "Molecular Cloning and Expression of the Type 1 and Type 2 Murine Receptors for Tumor Necrosis Factor", Molecular and Cellular Biology 11(6):3020-3026 (1991).
Gray et al., "Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein", Proc. Natl. Acad. Sci. USA 87:7380-7384 (1990).
Himmler et al., "Molecular Cloning and Expression of Human and Rat Tumor Necrosis Factor Receptor Chain (p60) and Its Soluble Derivative, Tumor Necrosis Factor-Binding Protein", DNA and Cell Biology 9(10):705-715 (1990).
Lee et al., "Targeted Mutation of the Gene Encoding the Low Affinity NGF Receptor p75 Leads to Deficits in the Peripheral Sensory Nervous System", Cell 69:737-749 (1992).
Lewis et al., "Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific", Proc. Natl. Acad. Sci. USA 88:2830-2834 (1991).
Loetscher et al., "Molecular Cloning and Expression of the Human 55 kd Tumor Necrosis Factor Receptor", Cell 61:351-359 (1990).
Mallett et al., "A new superfamily of cell surface proteins related to the nerve growth factor receptor", Immunology Today 12(7):220-223 (1991).
Mansour, "Gene Targeting in Murine Embryonic Stem Cells: Introduction of Specific Alterations into the Mammalian Genome", GATA 7(8):219-227 (1990).
Miethke et al., "T Cell-mediated Lethal Shock Triggered in Mice by the Superantigen Staphylococcal Enterotoxin B: Critical Role of Tumor Necrosis Factor", J. Exp. Med. 175:91-98 (1992).
Nophar et al., "Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor", The EMBO Journal 9:3269-3278 (1990).
Ohsawa et al., "Expression of Tumor Necrosis Factor at a Specific Developmental Stage of Mouse Embryos", Developmental Biology 135:459-461 (1989).
Pfeffer et al., "Mice Deficient for the 55 kd Tumor Necrosis Factor Receptor are Resistant to Endotoxic Shock, yet Succumb to L. monocytogenes Infection", Cell 73:457-467 (1993).
Robertson, "Using Embryonic Stem Cells to Introduce Mutations into the Mouse Germ Line", Biology of Reproductions 44:238-245 (1991).
Schall et al., "Molecular Cloning and Expression of a Receptor for Human Tumor Necrosis Factor", Cell. 61:361-370 (1990).
Smith et al., "A Receptor for Tumor Necrosis Factor Defines an Unusual Family of Cellular and Viral Proteins", Science 248:1019-1023 (1990).
Tartaglia et al., "Two TNF receptors", Immunology Today, 13(5):151-153 (1992).
Thomas et al., "Identification of a 60-kD Tumor Necrosis Factor (TNF) Receptor as the Major Signal Transducing Component in TNF Responses", J. Exp. Med. 172:1019-1023 (1990).
Thomas et al., "Site-Directed Mutagenesis by Gene Targeting in Mouse Embryo-Derived Stem Cells", Cell 51:503-512 (1987).
Tracey et al., "Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia", Nature 330:662-664 (1987).
Tracey et al., "Shock and Tissue Injury Induced by Recombinant Human Cachectin", Science 234:470-474 (1986).
Wiegmann et al., "Human 55-kDa Receptor for Tumor Necrosis Factor Coupled to Signal Transduction Cascades", J. Biol. Chem. 267(25):17997-18001 (1992).
Goodwin et al. 1991. Molecular and Cellular Biology 11(6):3020-3026.
Camerini et al. 1991. J. Immunol. 147(9):3165-3169.
Lee et al 1992. Cell 69:737-749.
Monsour et al 1990. Gene Analysis Tech Appl. (GATA) 7(8):219-227.
Robertson 1991 Biol. Rerod. 44:238-245.
Ontario Cancer Institute
Stanton Brian R.
LandOfFree
Mutant mouse having a disrupted TNFRp55 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutant mouse having a disrupted TNFRp55, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutant mouse having a disrupted TNFRp55 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1834664